Navigation Links
Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA® ER Designed to be Crush-Resistant
Date:1/7/2011

ww.endo.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the company's financial position, results of operations, market position, product development and business strategy, as well as estimates of future net sales, future expenses, future net income and future earnings per share. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "intend," "guidance" or similar expressions are forward-looking statements. Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2009 and Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 and as otherwise enumerated herein or therein, could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained in our Annual Report on Form 10-K. Important factors that could cause our actual results to differ materially from the expectations reflected in the forward-looking statements in our Annual Report on Form 10-K include those factors described herein under the caption "Risk Factors" and in documents incorporated by reference, including, among others: our ability to successfully develop, commercialize and market new products; timing and results of pre-clinical or clinical trials on new products; our ability to obtain regulatory approval of any of our pipeline products; competition for the business of our branded and generic products, and in connection with our acquisition of rights to intell
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... YORK , Aug. 27, 2014 ... is available in its catalogue: Global ... http://www.reportlinker.com/p02316641/Global-Animal-Health-Market-2014-2018.html About Animal Health Animal ... animal diseases or treat animals to enhance their ... the yield of animal food. The Global Animal ...
(Date:8/27/2014)... , Aug. 27, 2014 North American lighting ... prestigious R&D 100 Award for the new OSRAM ITOS ® ... LED-based white light module for microscopy, endoscopy and surgical head ... with significantly higher efficacy and lamp life. "We,re ... one of the most innovative new technologies of the past ...
(Date:8/27/2014)... , Aug. 27, 2014  CVS Caremark (NYSE: ... a new clinical affiliation with MedStar Health, a leading ... Maryland and the Washington, DC ... affordable health care services for patients. Through this clinical ... to clinical support, medication counseling, chronic disease monitoring and ...
Breaking Medicine Technology:Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3
(Date:8/27/2014)... in health care spending for commercially insured individuals is ... rather than increased use, according to a new study ... Policy & Clinical Practice, published in the August issue ... , There is increasing concern that consolidation in the ... by payers and, ultimately, consumers," said Carrie Colla, PhD, ...
(Date:8/27/2014)... 27, 2014 Scientists at The Scripps Research Institute ... signaling pathway can be associated with alcohol dependence. ... called neurofibromatosis type 1 (Nf1), which TSRI scientists found ... research shows Nf1 regulates gamma-aminobutyric acid (GABA), a neurotransmitter ... , "This novel and seminal study provides insights into ...
(Date:8/27/2014)... Dr. Winifred S. Hayes, President and CEO ... better health outcomes through the use of evidence, is ... to the executive team effective August 25, 2014. As ... responsible for providing innovation, leadership, and direction in the ... all markets. , “Maura is a highly respected ...
(Date:8/27/2014)... and dad, especially when your infant looks at you ... prattling, but by listening and responding, they let their ... forming complex sounds and using language more quickly. , ... of Iowa and Indiana University that found how parents ... way infants communicate and use vocalizations. , The findings ...
(Date:8/27/2014)... 2014 Will Holbrook, CP LP, has ... has over 15 years of experience in the prosthetics ... Georgia with a Bachelor of Science degree with a ... He received his graduate degree in prosthetics at Northwestern ... have Will join us at Fourroux,” says Keith Watson, ...
Breaking Medicine News(10 mins):Health News:Tracking spending among the commercially insured 2Health News:Scripps Research Institute scientists link alcohol-dependence gene to neurotransmitter 2Health News:Maura Connor Joins Hayes, Inc. as Vice President, Digital Publishing, Editor-in-Chief 2Health News:Parents, listen next time your baby babbles 2Health News:Parents, listen next time your baby babbles 3
... inadequate resources provided by the government to help the ... of treatment has left many stroke victims invalid. According ... with timely treatment and quality care. ,The ... victims with immediate brain scans, appropriate medication to dissolve ...
... a grant of $6 million for the Florida State ... for dyslexia in children.// The schedule involves understanding, ... grant will fund the creation of a National Institutes ... The center, which will be one of only four ...
... breast cancer who have been receiving the 30-year-old tamoxifen ... with the drug, Arimidex// under a new European licence ... AstraZeneca has stated that Arimidex, an aromatase inhibitor, will ... a partial course of tamoxifen.The license for this switch ...
... pass a law that would protect HIV/AIDS patient's rights to ... right// for a woman with the right to seek an ... ,India is supposedly the country with the highest number of ... this bill is being proposed to control this problem at ...
... the leading developmental disability. Statistics show that about 1.5 million ... a 10-17% increase in the disease ratio every year//. ... symptoms known to everyone the cause of the disease still ... brain developed by Dr. Stephen Grossberg, professor and chairman of ...
... taking part in an initiative to gauge if any ... who have suffered a stroke recently//. The MíTICO study ... Ictus. ,The study included patients from different Autonomous ... three months previously. By means of periodical controls, a ...
Cached Medicine News:Health News:Research Fund for FSU to Eradicate Dyslexia 2Health News:New Law On HIV/AIDS To Be Implemented At The Monsoon Session Of Parliament 2Health News:iSTART Brain Model Reveals the possible Cause of Autism 2Health News:iSTART Brain Model Reveals the possible Cause of Autism 3
Patent Pending lateral flow assay platform that contributes to increased sensitivty...
Iso-Electric Determination Kit; contains 1 bottle of 40 nm Naked Gold Iso-Electric Determination Kit to optimize gold conjugation of antibodies...
Gold Labeling kit for antibodies, the Coat-Block-Run Conjugation Kit pH 5-8; contains 1 bottle each of 20 nm and 40 nm Naked Gold...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: